| PROTOCOL FOR COLLECTION OF AGGREGATE STATISTICS |
|
| Purpose: We will use aggregate statistics to support our evaluation, focusing on data system contents, linking results, and ultimate system and client outcomes. |
|
| Data Collection: We will use our contacts with the technical assistance provider (TAP) and semi-structured interviews to facilitate procuring aggregate statistics. We will work with the TAP to gather these data from jurisdictions quarterly. |
We will collect a core set of measures (phase 1), followed by an additional set of phase 2 measures. Phase 2 measures will only be phased in once sites accomplish phase 1 reporting. We will coordinate with the TAP to determine when phase 2 reporting will occur. Readiness may vary by jurisdcition.
|
| We provide a summary overview of measures and samples in the "Summary Measures" and "Summary Samples" sheets. |
|
| Reporting Templates: The Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB) performance measures and measures related to STI and HIV surveillance data are provided in the "Detailed HAB PM & Addl. Measures" sheet. These measures apply to all jurisdictions. |
|
| The measures related to the TAP-identified TA focus areas are provided in the "Jurisdiction TA Measures" sheet. We indicate which measures apply to all jurisdictions and the measures specific to the individual jurisdictions based on TA needs. |
|
| We provide measure descriptions, and if applicable, specifications for numerators, denominators, and exclusion criteria. |
|
| For further guidance on the HAB performance measures, please refer to: https://hab.hrsa.gov/clinical-quality-management/performance-measure-portfolio |
|
| All aggregate data will be submitted securely using Box. |
|
| Note: Ryan White HIV/AIDS Program is abbreviated as RWHAP in this document |
Phase 1
Samples: All PWH; separately, RWHAP clients
Stratified by: Age, sex at birth, gender identity, race/ethnicity, and risk categories* |
Phase 2
Samples: All PWH; separately, RWHAP clients; PWH with an STI co-infection;** separately RWHAP clients with an STI co-infection
Stratified by: Age, sex at birth, gender identity, race/ethnicity, and risk categories* |
| Measures |
Reporting Frequency |
Measures |
Reporting Frequency |
| HIV viral load suppression |
Quarterly |
HIV viral load suppression |
Quarterly |
| Retention in care |
Quarterly |
Retention in care |
Quarterly |
| Linkage to HIV medical care |
Quarterly |
Linkage to HIV medical care |
Quarterly |
| Unmet need for HIV medical care |
Quarterly |
Unmet need for HIV medical care |
Quarterly |
| Reengaged in care |
Quarterly |
Reengaged in care |
Quarterly |
| Partners identified by people newly diagnosed with HIV (of those who consented to partner services) |
Quarterly |
Partners identified by people newly diagnosed with HIV (of those who consented to partner services) |
Quarterly |
| Partners identified by people newly diagnosed with syphilis (of those who consented to partner services) |
Quarterly |
Partners identified by people newly diagnosed with syphilis (of those who consented to partner services) |
Quarterly |
| Jurisdiction TA Measures (Refer to Jurisdiction TA Measures sheet) |
Quarterly |
Jurisdiction TA Measures (Refer to Jurisdiction TA Measures sheet) |
Quarterly |
| *As reported in eHARS |
|
Late HIV diagnosis |
Quarterly |
|
|
Treatment for syphilis*** |
Quarterly |
|
|
Partner contact attempts for people newly diagnosed with HIV (of those who consented to partner services) |
Quarterly |
|
|
Partner contact attempts for people newly diagnosed with syphilis (of those who consented to partner services) |
Quarterly |
|
|
*As reported in eHARS |
|
|
|
**Sample inclusion criteria for Phase 2 (STI co-infection) |
|
|
|
***For syphilis co-infection samples only |
|
| AGGREGATE STATISTICS - HIV/STI SURVEILLANCE, HIV CARE CONTINUUM, SCREENING & LINKAGE TO CARE OF PARTNERS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Phase |
Aggregate measures |
Reporting Frequency |
Description |
Denominator |
Numerator |
Exclusions |
Denominator |
Numerator |
| Phase 1 |
HIV viral load suppression |
Quarterly |
Percentage of patients, regardless of age, with a diagnosis of HIV with a HIV viral load less than 200 copies/ml at last viral load test during the measurement year (per HRSA HAB performance measure definition, or as operationalized by jurisdiction with support from TAP - if operationalized differently, provide definition) |
Number of patients, regardless of age, with a diagnosis of HIV with at least one medical visit in the measurement year |
Number of patients in the denominator with a HIV viral load less than 200 copies/ml at last HIV viral load test during the measurement year |
None |
N |
N |
| Phase 1 |
Retention in care |
Quarterly |
Percentage of patients, regardless of age, with a diagnosis of HIV who had at least two (2) encounters within the 12-month measurement year (per HRSA HAB performance measure definition, or as operationalized by jurisdiction with support from TAP - if operationalized differently, provide definition) |
Number of patients, regardless of age, with a diagnosis of HIV who had at least one HIV medical encounter within the 12-month measurement year. An HIV medical care encounter is a medical visit with a provider with prescribing privileges or an HIV viral load test. |
Number of patients in the denominator who had at least two HIV medical care encounters at least 90 days apart within a 12-month measurement year. At least one of the two HIV medical care encounters needs to be a medical visit with a provider with prescribing privileges. |
Patients who died at any time during the measurement year. |
N |
N |
| Phase 1 |
Linkage to HIV medical care |
Quarterly |
Percentage of patients, regardless of age, who attended a routine HIV medical care visit within 1 month of HIV diagnosis (per HRSA HAB performance measure definition, or as operationalized by jurisdiction with support from TAP - if operationalized differently, provide definition) |
Number of patients, regardless of age, with an HIV diagnosis in the 12- month measurement year |
Number of patients who attended a routine HIV medical care visit within 1 month of HIV diagnosis |
None |
N |
N |
| Phase 1 |
Unmet need for HIV medical care |
Quarterly |
Percentage of patients, regardless of age, with a diagnosis of HIV who did not have a single CD4 count or viral load test conducted in measurement year (per HRSA HAB performance measure definition, or as operationalized by jurisdiction with support from TAP - if operationalized differently, provide definition) |
Number of patients, regardless of age, with a diagnosis of HIV |
Number of patients, regardless of age, with a diagnosis of HIV who did not have a single CD4 count or viral load test conducted in measurement year |
Patients who died at any time during the measurement year. |
N |
N |
| Phase 1 |
Reengaged in care |
Quarterly |
Percentage of patients, regardless of age, with a diagnosis of HIV who had at least one HIV medical encounter within the 12-month measurement year who were previously out of care (per HRSA HAB performance measure definition, or as operationalized by jurisdiction with support from TAP - if operationalized differently, provide definition) |
Number of patients, regardless of age, with a diagnosis of HIV who did not have a single HIV medical encounter in the year prior to the measurement year |
Number of patients, regardless of age, with a diagnosis of HIV who had at least one HIV medical encounter within the 12-month measurement year. An HIV medical care encounter is a medical visit with a provider with prescribing privileges or an HIV viral load test. |
Patients who died at any time during the measurement year. |
N |
N |
| Phase 1 |
Partners identified by people newly diagnosed with HIV |
Quarterly |
Number of individual partners named by newly diagnosed people during measurement period (HIV) |
Number of people newly diagnosed with HIV who consented to partner services |
Number of partners identified by people newly diagnosed with HIV who consented to partner services |
people newly diagnosed who did not consent to partner services |
N |
N |
| Phase 1 |
Partners identified by people newly diagnosed with Syphilis |
Quarterly |
Number of individual partners named by newly diagnosed people during measurement period (Syphilis) |
Number of people newly diagnosed with Syphilis who consented to partner services |
Number of partners identified by people newly diagnosed with Syphilis who consented to partner services |
people newly diagnosed who did not consent to partner services |
N |
N |
| Phase 2 |
Late HIV diagnosis |
Quarterly |
Percentage of patients with a diagnosis if Stage 3 HIV (AIDS) within 3 months if diagnosis of HIV |
Number of people with an HIV diagnosis in the 12-month measurement period |
Number of people with a diagnosis of Stage 3 HIV infection (AIDS) within 3 months of diagnosis of HIV infection in the 12- month measurement period |
None |
N |
N |
| Phase 2 |
Treatment for syphilis* |
Quarterly |
Percentage of syphilis cases identified within the measurement period receiving treatment for syphilis diagnosis |
Number of syphilis cases identified within the measurement period |
Number of syphilis cases identified within the measurement period receiving treatment for syphilis diagnosis |
None |
N |
N |
| Phase 2 |
Partner contact attempts for people newly diagnosed with HIV |
Quarterly |
Number of total attempts to contact partners during measurement period (HIV) |
Number of partners identified by people newly diagnosed with HIV who consented to partner services |
Number of attempts to reach partners identified by people newly diagnosed with HIV who consented to partner services |
people newly diagnosed who did not consent to partner services |
N |
N |
| Phase 2 |
Partner contact attempts for people newly diagnosed with Syphilis |
Quarterly |
Number of total attempts to contact partners during measurement period (Syphilis) |
Number of partners identified by people newly diagnosed with Syphilis who consented to partner services |
Number of attempts to reach partners identified by people newly diagnosed with Syphilis who consented to partner services |
people newly diagnosed who did not consent to partner services (need to review disposition codes) |
N |
N |
| *For syphilis co-infection samples only |
|
|
|
|
|
|
|
|
| AGGREGATE STATISTICS - TA FOCUS AREAS |
|
|
|
|
|
|
|
|
|
|
|
| Jurisdiction |
Aggregate Measures |
Reporting Frequency |
Description |
Denominator |
Numerator |
| All |
Frequency of electronic matching of people-level HIV/STI surveillance data |
Quarterly |
Number of occurrences of electronic matching of people-level HIV/STI surveillance data within measurement period. |
N |
|
| All |
Linkage rate between HIV/STI surveillance data |
Quarterly |
Proportion of patients successfully linked between systems at the end of the measurement period; linkage defined as both systems containing the other system's peopleal identifiers. If successful linkage defined differently (may vary by jurisdiction) please specify. |
N |
N |
| All |
Proportion of exact matches between HIV/STI surveillance data |
Quarterly |
Proportion of exact matches on primary identifiers at the end of the measurement period, generally include Social Security Number, name (first, middle initial, last), and date of birth. There may be secondary identifiers such as geography, gender, race, and ethnicity. Definitions will vary by jurisdiction. |
N |
N |
| All |
Proportion of non-exact (fuzzy) matches between HIV/STI surveillance data |
Quarterly |
Proportion of non-exact (fuzzy) matches at the end of the measurement period. For example, there may be an exact match on a secondary identifier, but no exact match on primary identifiers. This may also include a match with a preponderance of close identifiers. Some of these may be logical, such as a “Meg Smith” and “Meaghan Smith” with very similar dates of birth from the same ZIP code. Some of these may use a distance algorithm, such as Soundex or Levenshtein distance. Definitions will vary by jurisdiction. |
N |
N |
| All |
Frequency of systematic data quality checks of integrated HIV/STI surveillance data |
Quarterly |
Number of occurrences during measurement period. Definition for data quality checks will vary by jurisdiction, please specify. |
N |
|
| All |
Proportion of updates to client records in integrated HIV/STI surveillance data system - first, last, or middle name |
Quarterly |
Proportion of name-related updates to client records at the end of the measurement period. |
N |
N |
| All |
Proportion of updates to client records in integrated HIV/STI surveillance data system - home address |
Quarterly |
Proportion of address-related updates to client records at the end of the measurement period. |
N |
N |
| All |
Proportion of updates to client records in integrated HIV/STI surveillance data system - contact information |
Quarterly |
Proportion of contact information-related updates (e.g., phone number, email addresses, emergency contacts) to client records at the end of the measurement period. |
N |
N |
| All |
Proportion of updates to client records in integrated HIV/STI surveillance data system - other (e.g., risk, lab information) |
Quarterly |
Proportion of updates related to other information (e.g., risk, lab information) at the end of the measurement period. |
N |
N |
| Florida |
Records in the STI surveillance database (STARS) before deduplication |
Quarterly |
Number of records before deduplication. |
N |
|
| Florida |
Records in the STI surveillance database (STARS) after deduplication |
Quarterly |
Number of records after deduplication. |
N |
|
| Florida |
Frequency of data sharing by HIV data systems (eHARS) |
Quarterly |
Number of occurrences within measurement period. |
N |
|
| Florida |
Frequency of data sharing by STI data systems (STARS) |
Quarterly |
Number of occurrences within measurement period. |
N |
|
| Florida |
Frequency of data sharing by Part A |
Quarterly |
Number of occurrences within measurement period. |
N |
|
| Florida |
Frequency of data sharing by Part B (ADAP database) |
Quarterly |
Number of occurrences within measurement period. |
N |
|
| Florida |
Frequency of data linkage between HIV section/STI surveillance and RW Part A (6 individual programs) systems |
Quarterly |
Number of occurrences within reporting period. |
N |
|
| Florida |
Frequency of data quality checks of linked system - HIV section/STI surveillance and RW Part A (6 individual programs) |
Quarterly |
Number of occurrences during measurement period. Definition for data quality checks will vary by jurisdiction, please specify. |
N |
|
| Alabama |
Frequency of Part B data received (i.e., from Jefferson County Facilities/UAB) |
Quarterly |
Number of occurrences within measurement period. |
N |
|
| Alabama |
Frequency of systematic quality checks of Part B data |
Quarterly |
Number of occurrences within measurement period. |
N |
|
| Washington, D.C. |
Frequency of data sharing between RW (CTD) and Surveillance (SID) systems |
Quarterly |
Number of occurrences within measurement period. |
N |
|
| Louisiana |
Frequency of data sharing between SHHP data systems - RW (CAREWare and PBM) to HIV (eHARS) |
Quarterly |
Number of occurrences within measurement period. |
N |
|
| Louisiana |
Frequency of data sharing between SHHP data systems - RW (CAREWare and PBM) to STI (PRISM) |
Quarterly |
Number of occurrences within measurement period. |
N |
|
| Louisiana |
Frequency of data sharing between SHHP data systems - HIV (eHARS) to STI (PRISM) |
Quarterly |
Number of occurrences within measurement period. |
N |
|
| Louisiana |
Frequency of data quality checks of SHHP data systems |
Quarterly |
Number of occurrences during measurement period. Definition for data quality checks will vary by jurisdiction, please specify. |
N |
|
| Louisiana |
Frequency of automated linkages between SHHP data systems |
Quarterly |
Number of occurrences within measurement period |
N |
|